The present invention is directed to compounds which inhibit prenyl-protein transferases, farnesyl-protein transferase and geranylgeranyl-protein transferase type I, and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and geranylgeranyl-protein transferase type I and the prenylation of the oncogene protein RAS.
本发明涉及抑制
戊二烯基蛋白转移酶、法尼基蛋白转移酶和
戊二烯基蛋白转移酶I型,以及癌
基因蛋白Ras的预醇化的化合物。本发明还涉及含有本发明化合物的化疗组合物,以及抑制法尼基蛋白转移酶和
戊二烯基蛋白转移酶I型以及癌
基因蛋白Ras的预醇化的方法。